Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Venlafaxine-induced depression of wind-up activity in mononeuropathic rats is potentiated by inhibition of brain 5-HT1A receptor expression in vivo.

Hernández A, Constandil L, Laurido C, Pelissier T, Marchand F, Ardid D, Alloui A, Eschalier A, Soto-Moyano R.

Int J Neurosci. 2004 Feb;114(2):229-42.

PMID:
14702210
2.

Blockade of supraspinal 5-HT1A receptors potentiates the inhibitory effect of venlafaxine on wind-up activity in mononeuropathic rats.

Marchand F, Pelissier T, Eschalier A, Ardid D, Alloui A, Soto-Moyano R, Mondaca M, Laurido C, Constandil L, Hernández A.

Brain Res. 2004 May 22;1008(2):288-92.

PMID:
15145768
3.
4.

5-HT1A receptor activation counteracts c-Fos immunoreactivity induced in serotonin neurons of the raphe nuclei after immobilization stress in the male rat.

Rioja J, Santín LJ, Doña A, de Pablos L, Minano FJ, Gonzalez-Baron S, Aguirre JA.

Neurosci Lett. 2006 Apr 24;397(3):190-5. Epub 2006 Jan 9.

PMID:
16406667
5.

The counteraction of opioid-induced ventilatory depression by the serotonin 1A-agonist 8-OH-DPAT does not antagonize antinociception in rats in situ and in vivo.

Guenther U, Manzke T, Wrigge H, Dutschmann M, Zinserling J, Putensen C, Hoeft A.

Anesth Analg. 2009 Apr;108(4):1169-76. doi: 10.1213/ane.0b013e318198f828.

PMID:
19299781
8.

SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue.

Scott C, Soffin EM, Hill M, Atkinson PJ, Langmead CJ, Wren PB, Faedo S, Gordon LJ, Price GW, Bromidge S, Johnson CN, Hagan JJ, Watson J.

Eur J Pharmacol. 2006 Apr 24;536(1-2):54-61. Epub 2006 Feb 28.

PMID:
16571351
9.

8-OH-DPAT-induced effects on prepulse inhibition: pre- vs. post-synaptic 5-HT1A receptor activation.

Gogos A, Kusljic S, van den Buuse M.

Pharmacol Biochem Behav. 2005 Jul;81(3):664-72.

PMID:
15955549
10.
11.

Role of serotonin-1A receptors in restraint-induced behavioral deficits and adaptation to repeated restraint stress in rats.

Haleem DJ, Samad N, Perveen T, Haider S, Haleem MA.

Int J Neurosci. 2007 Feb;117(2):243-57.

PMID:
17365111
12.

Investigation of mechanisms mediating 8-OH-DPAT-induced impairment of spatial memory: involvement of 5-HT1A receptors in the dorsal hippocampus in rats.

Egashira N, Yano A, Ishigami N, Mishima K, Iwasaki K, Fujioka M, Matsushita M, Nishimura R, Fujiwara M.

Brain Res. 2006 Jan 19;1069(1):54-62. Epub 2006 Jan 4.

PMID:
16386718
13.

Toward brain imaging of serotonin 5-HT1A autoreceptor internalization.

Zimmer L, Riad M, Rbah L, Belkacem-Kahlouli A, Le Bars D, Renaud B, Descarries L.

Neuroimage. 2004 Jul;22(3):1421-6.

PMID:
15219613
14.

Role of spinal 5-HT(1A) receptors in morphine analgesia and tolerance in rats.

Bardin L, Colpaert FC.

Eur J Pain. 2004 Jun;8(3):253-61.

PMID:
15109976
15.

Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.

Delgado M, Caicoya AG, Greciano V, Benhamú B, López-Rodríguez ML, Fernández-Alfonso MS, Pozo MA, Manzanares J, Fuentes JA.

Eur J Pharmacol. 2005 Mar 21;511(1):9-19.

PMID:
15777774
16.
17.

Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.

Hughes ZA, Starr KR, Langmead CJ, Hill M, Bartoszyk GD, Hagan JJ, Middlemiss DN, Dawson LA.

Eur J Pharmacol. 2005 Mar 7;510(1-2):49-57.

PMID:
15740724
18.

Antidepressant-like effect of 17beta-estradiol: involvement of dopaminergic, serotonergic, and (or) sigma-1 receptor systems.

Dhir A, Kulkarni SK.

Can J Physiol Pharmacol. 2008 Oct;86(10):726-35. doi: 10.1139/y08-077.

PMID:
18841177
19.

Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors.

Ceglia I, Acconcia S, Fracasso C, Colovic M, Caccia S, Invernizzi RW.

Br J Pharmacol. 2004 Jun;142(3):469-78. Epub 2004 May 17.

20.

Supplemental Content

Support Center